Virtual screening of FOXO3a activators from natural product-like compound library-Reference-Cited by-同舟云学术

Virtual screening of FOXO3a activators from natural product-like compound library

Published:2023-06-01 Issue: Volume: Page:
ISSN:1381-1991
Container-title:Molecular Diversity
language:en
Short-container-title:Mol Divers

Author:

Manoharan Suryaa,Prajapati Kunjkumar,Karthikeyan Tharini,Vedagiri Hemamalini,Perumal Ekambaram

Funder

Rashtriya Uchchatar Shiksha Abhiyan

Publisher

Springer Science and Business Media LLC

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Drug Discovery,Molecular Biology,General Medicine,Information Systems,Catalysis

Link

https://link.springer.com/content/pdf/10.1007/s11030-023-10664-0.pdf

Reference59 articles.

1. Gaidai O, Yan P, Xing Y (2023) Future world cancer death rate prediction. Sci Rep 13:303. https://doi.org/10.1038/s41598-023-27547-x

2. Malik D, Mahendiratta S, Kaur H, Medhi B (2021) Futuristic approach to cancer treatment. Gene 805:145906. https://doi.org/10.1016/j.gene.2021.145906

3. Gyamfi J, Kim J, Choi J (2022) Cancer as a metabolic disorder. Int J Mol Sci 23:1155. https://doi.org/10.3390/ijms23031155

4. Li H, Yuan Y, Dong H et al (2023) Foxo3a-mediated DNMT3B impedes cervical cancer cell proliferation and migration capacities through suppressing PTEN promoter methylation. J Invest Surg. https://doi.org/10.1080/08941939.2022.2162170

5. Liu Y, Wang Y, Li X et al (2022) FOXO3a in cancer drug resistance. Cancer Lett 540:215724. https://doi.org/10.1016/j.canlet.2022.215724

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of potent STAT3 inhibitors using structure-based virtual screening, molecular dynamic simulation, and biological evaluation;Frontiers in Oncology;2023-11-02